Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia
Clinical trial NCT02360657 · COMPLETED
Trial details
- NCT number
- NCT02360657
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-16
- Primary completion
- 2015-09-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.